NT5E and cancer: For the first time, the aggregation and promiscuous inhibition issues were systematically studied and evaluated for compounds selected as potential inhibitors of human ecto-5′-NT (CD73), an enzyme that has increasingly attracted attention of scientific community due to its potential as a biological target for many diseases and pathophysiological conditions, especially inflammation, immune imbalance and cancer.